New study sees if tracking Alzheimer's drug in daily life helps families
NCT ID NCT06285448
First seen Feb 01, 2026 · Last updated May 15, 2026 · Updated 16 times
Summary
This study tests whether a registry can collect real-world information from people with Alzheimer's who take lecanemab and their care partners. The goal is to see if it's possible to track outcomes like quality of life and caregiver burden outside of a formal clinical trial. About 20 patient-care partner pairs will participate for up to 12 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
HealthPartners Neuroscience Center
Saint Paul, Minnesota, 55130, United States
Conditions
Explore the condition pages connected to this study.